Atricure Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Atricure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
/ 
Frequently asked questions
To buy Atricure Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Atricure Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Atricure Inc. is ATRC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Atricure Inc. has its primary listing on NASDAQ. You can trade Atricure Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Atricure Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Atricure Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Atricure Inc..